Harrington Scholar-Innovator Grant Program

Funding Agency:
University Hospitals Harrington Discovery Institute

Harrington Discovery Institute at University Hospitals is now accepting Letters of Intent for the 2024 Harrington Scholar-Innovator Award for physician-scientists. The award offers successful applicants multiple opportunities for funding in addition to expertise from pharma-experienced leaders with a track record of bringing drugs to market. Intellectual property rights are retained by the award recipient or their institution. Up to 12 Scholar-Innovators will be selected to receive:

  • $100,000 guaranteed grant award;
  • Drug and business development support from Harrington’s Therapeutics Development Center advisors;
  • Opportunity to compete for acceleration funds up to $300,000;
  • Opportunity to qualify for investment funds typically up to $2MM.


  • Mandatory LOI Submission Deadline: June 5, 2023

  • Full Proposal Deadline for those Invited: Aug. 7, 2023

Agency Website

Areas of Interest

The Harrington Scholar-Innovator award selection committee seeks breakthrough discoveries defined by innovation, creativity and potential for clinical impact, including:

  • Discoveries deemed to address unmet medical needs
  • Modulators of novel targets
  • Potential to be developed into a commercial program
  • Strong intellectual property (IP) or protection strategy
  • May be a small molecule, biologic, or other therapeutic modality
  • Diagnostics or devices only acceptable as part of a therapeutic development project

Eligibility Requirements

The call is open to physician-scientists at accredited academic medical centers, research institutions and universities in the United States and Canada. Selection criteria include innovationcreativity and potential for impact on human health. Applicants must have a doctorate in medicine. 



Funding Type





Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

June 5, 2023